Navigation Links
ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
Date:4/29/2010

WASHINGTON, April 29, 2010 The American Chemical Society Green Chemistry Institute (ACS GCI) Pharmaceutical Roundtable has awarded its 2010 research grant to Scottish chemist David Cole-Hamilton, Ph.D., for making great strides in expanding green chemistry and engineering practices in the global pharmaceutical industry. Cole-Hamilton will use the one-year $150,000-grant to further his study of the hydrogenation of amides to amines, resulting in improved benefits for the environment. He is the Irvine Professor of Chemistry, EaStCHEM, University of St. Andrews, Scotland.

Cole-Hamilton's research seeks to provide safer and environmentally friendly solutions to convert amides to amines, important in the development of many pharmaceutically active compounds. Conversion of the amide to the amine is usually conducted using a metallic hydride source such as sodium borohydride or lithium aluminum hydride.

The reactions are stoichiometric and large amounts of aluminum- or boron- containing side products are formed. Requiring separation from the desired amine product, these side products are usually disposed of in a landfill. The Roundtable identified greener amide reductions as one of the 12 key green chemistry research areas important for the pharmaceutical industry.

Cole-Hamilton's study will build upon exciting preliminary results, which proved it should be possible to use catalytic amide hydrogenation, which would only give water as a side product. If the catalyst is very active or can be recycled, there is no need for any significant waste from this reaction.

Since 2007 the grant program has awarded $800,000 toward research in the 12 key green chemistry research areas. All funding is made possible by a partnership between the ACS GCI and an alliance of major pharmaceutical companies Abbott Laboratories, AstraZeneca, Boehringer Ingelheim, Codexis, Dr. Reddy's, DSM Pharmaceutical Products, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis, Pfizer, and Roche.

Under the leadership of Cole-Hamilton, the St. Andrews group will collaborate with members of the Roundtable to improve the technology and allow it to be introduced widely and without restriction into the pharmaceutical industry. Major targets will be lowering the temperature and especially the pressure at which reactions are carried out, improving the selectivity toward the desired amines (currently 85-90 percent, with alcohols as the side products) and exploring scope and the functional group tolerance of the reaction.


'/>"/>

Contact: Julie Manley
j_manley@acs.org
815-325-4974
American Chemical Society
Source:Eurekalert  

Related biology news :

1. Study gives green light to plants’ role in global warming
2. Georgia Powers Green Energy Program Redesigned to Include More Solar Power
3. New York City Regional Extension Center Selects Greenway
4. New evidence that green tea may help fight glaucoma and other eye diseases
5. From bacteria to electricity: The future of green energy
6. Demystifying yield fluctuations for greenhouse tomatoes
7. Solid-state illuminator reduces nitrates in leafy green vegetables
8. Global study shows health joins green as business strategy
9. Early Earth absorbed more sunlight -- no extreme greenhouse needed to keep water wet
10. Spray application rate, equipment affect pest management in greenhouse ivy plants
11. More maize ethanol may boost greenhouse gas emissions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/15/2016)... , Jan. 15, 2016 Recent publicized ... small to find new ways to ensure data security ... iOS and Android that ties ... biometrics, transforming it into a hardware authorization token. Customer ... swipe their fingerprint on their KodeKey enabled device to ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):
(Date:2/12/2016)... SAN DIEGO , Feb. 12, 2016 Biocom, ... life science community, took a group of San ... as part of its 2016 Precision Medicine Advocacy Fly-In. ... at the Food and Drug Administration (FDA), the Centers for ... (NIH), as well as San Diego U.S. Representatives Susan ...
(Date:2/12/2016)... MedGenome,s Commitment Will Help ... of Complex Diseases Such as Cancer, Metabolic Disorders, ... --> --> MedGenome, the market ... leading provider of genomics research services globally, today ... GenomeAsia 100K consortium as a founding member. ...
(Date:2/11/2016)... Germany and GERMANTOWN, Maryland ... QGEN ; Frankfurt Prime Standard: QIA) today announced the ... Panels for gene expression profiling, expanding QIAGEN,s portfolio of ... panels enable researchers to select from over 20,000 human ... discover interactions between genes, cellular phenotypes and disease processes. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and ... premier sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in ...
Breaking Biology Technology: